feed,title,long_url,short_url
InsiderMonkey,Why Eli Lilly (LLY) is Emerging as a Dividend Growth Leader in Pharma for 2025,https://insidermonkey.com/blog/--1571362,
InsiderMonkey,Thermo Fisher Scientific’s (TMO) Dividend: Steady Payouts in a Growing Market,https://insidermonkey.com/blog/--1571361,
InsiderMonkey,Pfizer’s (PFE) Dividend Safety: Balancing Innovation and Shareholder Returns,https://insidermonkey.com/blog/--1571360,
InsiderMonkey,Merck’s (MRK) Dividend History: A Track Record of Consistency,https://insidermonkey.com/blog/--1571359,
InsiderMonkey,Johnson & Johnson’s (JNJ) Dividend Track Record: Reliability in Uncertain Times,https://insidermonkey.com/blog/--1571357,
InsiderMonkey,Why AbbVie (ABBV) Remains a Dividend Standout in the Pharma Sector,https://insidermonkey.com/blog/--1571358,
InsiderMonkey,Why Gilead Sciences (GILD) Appeals to Income Investors in the Pharma Sector,https://insidermonkey.com/blog/--1571356,
InsiderMonkey,CVS Health’s (CVS) Dividend Outlook: Can the Retail-Pharma Giant Deliver in 2025?,https://insidermonkey.com/blog/--1571348,
InsiderMonkey,How Abbott Laboratories (ABT) Balances Innovation with Shareholder Payouts,https://insidermonkey.com/blog/--1571345,
InsiderMonkey,Why Amgen (AMGN) Could Be a Hidden Gem Among Dividend Pharma Stocks in 2025,https://insidermonkey.com/blog/--1571344,
InsiderMonkey,Why Income Investors Are Watching Bristol-Myers Squibb Company (BMY) in 2025,https://insidermonkey.com/blog/--1571343,
